IRCT20200608047686N1
Completed
Phase 2
Evaluation of therapeutic effects of Metronidazole In Inpatients with Pneuomonia Due to COVID-19
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- COVID-19.
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inpatients with Pneuomonia Due to COVID\-19
Exclusion Criteria
- •Hypersensitivity Reactions to Metronidazole
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Effect of Variable Doses of Metronidazole in Treatment of HelicobacterpyloriHelicobacter pylori Infection.Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhereB96.81IRCT20211012052740N1Oroumia University of Medical Sciences170
Recruiting
Phase 3
Effect of Topical Metronidazole in treatment of chronic fissureChronic Anal Fissure.Chronic anal fissureK60.1IRCT20221102056377N1Shahid Beheshti University of Medical Sciences54
Completed
Phase 2
Application of antimicrobial gel aiming to treat periodontal disease (gingival disease)Periodontal disease/Chronic periodontitisC07.465.714.533.324RBR-68bwkcFaculdade De Odontologia de Ribeirão Preto
Recruiting
Phase 3
The effect of metronidazole and levofloxacin on increased IVF success rateIRCT20200825048515N24Esfahan University of Medical Sciences260
Not yet recruiting
Phase 2
The effect of antibiotics on reducing infectioAcute appendicitis.Acute appendicitisIRCT20160523028008N12Shahid Beheshti University of Medical Sciences200